FDA clears Merck's Keytruda for cancer patients with certain biomarkers
May 23, 2017 at 15:33 PM EDT
May 23 (Reuters) - The U.S. Food and Drug Administration on Tuesday approved Merck & Co's immuno-oncology treatment, Keytruda, for cancer patients who carry a specific genetic feature.
